FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109064013> ?p ?o ?g. }

• W2109064013 endingPage "230" @default.
• W2109064013 startingPage "230" @default.
• W2109064013 abstract "Antiretroviral therapy (ART) suppresses HIV viral load in all body compartments and so limits the risk of HIV transmission. It has been suggested that ART not only contributes to preventing transmission at individual but potentially also at population level. This trial aims to evaluate the effect of ART initiated immediately after identification/diagnosis of HIV-infected individuals, regardless of CD4 count, on HIV incidence in the surrounding population. The primary outcome of the overall trial will be HIV incidence over two years. Secondary outcomes will include i) socio-behavioural outcomes (acceptability of repeat HIV counselling and testing, treatment acceptance and linkage to care, sexual partnerships and quality of life); ii) clinical outcomes (mortality and morbidity, retention into care, adherence to ART, virologic failure and acquired HIV drug resistance), iii) cost-effectiveness of the intervention. The first phase will specifically focus on the trial’s secondary outcomes. A cluster-randomised trial in 34 (2 × 17) clusters within a rural area of northern KwaZulu-Natal (South Africa), covering a total population of 34,000 inhabitants aged 16 years and above, of whom an estimated 27,200 would be HIV-uninfected at start of the trial. The first phase of the trial will include ten (2 × 5) clusters. Consecutive rounds of home-based HIV testing will be carried out. HIV-infected participants will be followed in dedicated trial clinics: in intervention clusters, they will be offered immediate ART initiation regardless of CD4 count and clinical stage; in control clusters they will be offered ART according to national treatment eligibility guidelines (CD4 <350 cells/μL, World Health Organisation stage 3 or 4 disease or multidrug-resistant/extensively drug-resistant tuberculosis). Following proof of acceptability and feasibility from the first phase, the trial will be rolled out to further clusters. We aim to provide proof-of-principle evidence regarding the effectiveness of Treatment-as-Prevention in reducing HIV incidence at the population level. Data collected from the participants at home and in the clinics will inform understanding of socio-behavioural, economic and clinical impacts of the intervention as well as feasibility and generalizability. Clinicaltrials.gov: NCT01509508 ; South African Trial Register: DOH-27-0512-3974." @default.
• W2109064013 created "2016-06-24" @default.
• W2109064013 creator A5003138186 @default.
• W2109064013 creator A5005072339 @default.
• W2109064013 creator A5005939121 @default.
• W2109064013 creator A5012288385 @default.
• W2109064013 creator A5031518026 @default.
• W2109064013 creator A5047839783 @default.
• W2109064013 creator A5049406372 @default.
• W2109064013 creator A5049440373 @default.
• W2109064013 creator A5062996779 @default.
• W2109064013 creator A5068683601 @default.
• W2109064013 creator A5077160522 @default.
• W2109064013 date "2013-01-01" @default.
• W2109064013 modified "2023-10-18" @default.
• W2109064013 title "Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial" @default.
• W2109064013 cites W1964867999 @default.
• W2109064013 cites W1973540642 @default.
• W2109064013 cites W1978056040 @default.
• W2109064013 cites W1980187601 @default.
• W2109064013 cites W1981374026 @default.
• W2109064013 cites W1984588017 @default.
• W2109064013 cites W2001602693 @default.
• W2109064013 cites W2002278041 @default.
• W2109064013 cites W2002851422 @default.
• W2109064013 cites W2013194745 @default.
• W2109064013 cites W2020671331 @default.
• W2109064013 cites W2035384552 @default.
• W2109064013 cites W2036408211 @default.
• W2109064013 cites W2036541374 @default.
• W2109064013 cites W2052191760 @default.
• W2109064013 cites W2067997434 @default.
• W2109064013 cites W2104051084 @default.
• W2109064013 cites W2108259145 @default.
• W2109064013 cites W2108531049 @default.
• W2109064013 cites W2114900754 @default.
• W2109064013 cites W2117627726 @default.
• W2109064013 cites W2127832030 @default.
• W2109064013 cites W2128229768 @default.
• W2109064013 cites W2131295062 @default.
• W2109064013 cites W2140083708 @default.
• W2109064013 cites W2143265231 @default.
• W2109064013 cites W2150047352 @default.
• W2109064013 cites W2152505869 @default.
• W2109064013 cites W2153356886 @default.
• W2109064013 cites W2165411092 @default.
• W2109064013 cites W2168841389 @default.
• W2109064013 cites W2314461521 @default.
• W2109064013 doi "https://doi.org/10.1186/1745-6215-14-230" @default.
• W2109064013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3750830" @default.
• W2109064013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23880306" @default.
• W2109064013 hasPublicationYear "2013" @default.
• W2109064013 type Work @default.
• W2109064013 sameAs 2109064013 @default.
• W2109064013 citedByCount "107" @default.
• W2109064013 countsByYear W21090640132013 @default.
• W2109064013 countsByYear W21090640132014 @default.
• W2109064013 countsByYear W21090640132015 @default.
• W2109064013 countsByYear W21090640132016 @default.
• W2109064013 countsByYear W21090640132017 @default.
• W2109064013 countsByYear W21090640132018 @default.
• W2109064013 countsByYear W21090640132019 @default.
• W2109064013 countsByYear W21090640132020 @default.
• W2109064013 countsByYear W21090640132021 @default.
• W2109064013 countsByYear W21090640132022 @default.
• W2109064013 countsByYear W21090640132023 @default.
• W2109064013 crossrefType "journal-article" @default.
• W2109064013 hasAuthorship W2109064013A5003138186 @default.
• W2109064013 hasAuthorship W2109064013A5005072339 @default.
• W2109064013 hasAuthorship W2109064013A5005939121 @default.
• W2109064013 hasAuthorship W2109064013A5012288385 @default.
• W2109064013 hasAuthorship W2109064013A5031518026 @default.
• W2109064013 hasAuthorship W2109064013A5047839783 @default.
• W2109064013 hasAuthorship W2109064013A5049406372 @default.
• W2109064013 hasAuthorship W2109064013A5049440373 @default.
• W2109064013 hasAuthorship W2109064013A5062996779 @default.
• W2109064013 hasAuthorship W2109064013A5068683601 @default.
• W2109064013 hasAuthorship W2109064013A5077160522 @default.
• W2109064013 hasBestOaLocation W21090640131 @default.
• W2109064013 hasConcept C119599485 @default.
• W2109064013 hasConcept C120665830 @default.
• W2109064013 hasConcept C121332964 @default.
• W2109064013 hasConcept C126322002 @default.
• W2109064013 hasConcept C127413603 @default.
• W2109064013 hasConcept C142462285 @default.
• W2109064013 hasConcept C164866538 @default.
• W2109064013 hasConcept C168563851 @default.
• W2109064013 hasConcept C187212893 @default.
• W2109064013 hasConcept C199360897 @default.
• W2109064013 hasConcept C2777931914 @default.
• W2109064013 hasConcept C2908647359 @default.
• W2109064013 hasConcept C2993143319 @default.
• W2109064013 hasConcept C3013748606 @default.
• W2109064013 hasConcept C41008148 @default.
• W2109064013 hasConcept C512399662 @default.
• W2109064013 hasConcept C535046627 @default.
• W2109064013 hasConcept C61511704 @default.
• W2109064013 hasConcept C71924100 @default.

• next